Vandana Singh - Spark Newswire

1 minute read

Despite Trial Failure Praxis Still Seeks Advancing Essential Tremor Program Into Phase 3 Study

Today, 3:12 PM

Praxis Precision Medicines Inc (NASDAQ:PRAX) announced topline results from the Essential1 study evaluating the efficacy, safety, and tolerability of ulixacaltamide (PRAX-944)…

PRAX

1 minute read

$300B California Teachers Pension Fund Joins Politan Capital In Legal Action Against Masimo CEO’s Employment Agreement

By Vandana Singh

Today, 3:12 PM

The California State Teachers’ Retirement System (CalSTRS) has joined Politan Capital Management to stop Masimo Corp’s (NASDAQ:MASI) CEO from receiving…

MASI

1 minute read

Walgreens Boots Alliance Nixes Dispersing Abortion Medication In 20 Republican States

By Vandana Singh

Today, 3:12 PM

Walgreens Boots Alliance Inc (NASDAQ: WBA) reportedly confirmed that it would not dispense abortion pills in several states where they remain legal.

WBA

2 minute read

Biden Admin’s Upcoming Cybersecurity Strategy Can Potentially Put Businesses, Software Provides On Collision Course

By Vandana Singh

Today, 3:12 PM

The Biden administration is poised to release a new national cybersecurity strategy that aims to make software companies liable for security hacks rather than the companies facing the hack.

AMZN

1 minute read

UBS Expects Retail Inflow Of Around $87B Driving Next Leg Of Chinese Stock Rally: Report

By Vandana Singh

Today, 3:12 PM

According to UBS Group AG (NYSE: UBS), China's stock market may see an inflow of around 600 billion yuan ($86.8 billion) of excess savings from the nation's households.

FXI

1 minute read

Valneva Shares Updated Data From Now Shelved COVID-19 Vaccine Development Program

By Vandana Singh

Today, 3:12 PM

As previously announced, Valneva SE (NASDAQ:VALN) said it would not invest in further COVID-19 vaccine development, VLA2001, without a new…

AZN

1 minute read

FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK’s Candidate Soon After Pfizer’s

By Vandana Singh

Today, 3:12 PM

The FDA’s Vaccines and Related Biological Products Advisory Committee voted that GSK plc’s (NYSE:GSK) available data support the safety and effectiveness of…

GSK

1 minute read

AbbVie Can Write Diversified Growth Story Without Humira, Rest Of The Business Has Strength, Analyst Says

By Vandana Singh

Today, 3:12 PM

Guggenheim initiated coverage on AbbVie Inc (NYSE:ABBV) with a Buy and a price target of $172 on diversified growth. Investors have “naturally” been…

ABBV

1 minute read

JNJ’s Consumer Health Business Separation Will Remove Uncertainty Cloud From Company: Why This Analyst Wants Visibility

By Vandana Singh

Today, 3:12 PM

Guggenheim initiated the coverage on Johnson & Johnson (NYSE:JNJ) with a Neutral rating and a $161 price target. The analyst agrees with the…

JNJ

1 minute read

Analyst Sits On Fence While Initiating Calliditas Citing ‘Near-Term Opportunity But Longer-Term Questions’

By Vandana Singh

Today, 3:12 PM

Guggenheim initiated coverage on Calliditas Therapeutics AB (NASDAQ:CALT) with a Neutral rating and an $18 price target. The analyst is impressed with…

CALT